| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/11/2001 | CN1291100A Cyclopentane Heptan (ene) oic acid, 2-hetero arylakenyl derivatives and therapeutic agents |
| 04/11/2001 | CN1291099A Heterocyclic compounds, their, production and use |
| 04/11/2001 | CN1291098A Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors |
| 04/11/2001 | CN1291097A Morphine sulphate microgranules, method for making same and pharmaceutical preparations |
| 04/11/2001 | CN1291095A Chemical compounds |
| 04/11/2001 | CN1291094A Bicyclic pyrrole derivatives as MCP-1 inhibitor |
| 04/11/2001 | CN1291093A Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |
| 04/11/2001 | CN1291092A pharmaceutical Combinations containing tramadol |
| 04/11/2001 | CN1291091A Orally administrable immediate and prolonged-release Galenic form comprising absorption-promoting agent and use of this absorption-promoting agent |
| 04/11/2001 | CN1290703A New metal protease inhibitors, its preparing method and their medicinal composition containing them |
| 04/11/2001 | CN1290701A Flavone chromium and its producing method and use |
| 04/11/2001 | CN1290700A Phenyl piperazine derivatives |
| 04/11/2001 | CN1290698A Quinoline-4-base deviative I |
| 04/11/2001 | CN1290542A Tincture for curing skin diseases |
| 04/11/2001 | CN1290533A Medicine powder |
| 04/11/2001 | CN1290530A Aitongning plaster for cancer and its preparing method |
| 04/11/2001 | CN1290528A Chinese medicine for curing psychosis and its preparing method |
| 04/11/2001 | CN1290527A Skin-care cream |
| 04/11/2001 | CN1290526A Medicine for expelling live roundworn in biliary tract |
| 04/11/2001 | CN1290525A Freeze dried zhalaipulong instant oral composition |
| 04/11/2001 | CN1064372C Process for preparing transparent sodium hyaluronate prepartion |
| 04/11/2001 | CN1064371C Seaweed polysaccharide trace-element complex and its preparing method and use |
| 04/11/2001 | CN1064368C Fluoric steroid 5 alpha reductase inhibitor and synthesis process and use |
| 04/11/2001 | CN1064365C Mixed micelles |
| 04/11/2001 | CN1064363C Morphine and diamorphine salts of anionic non-narcotic analgesics of substituted carboxylic acid type |
| 04/11/2001 | CN1064362C Pyrimido [5,4-D] pyrimidines, medicine containing these compounds, their use and process for their production |
| 04/11/2001 | CN1064361C Xanthine compounds having terminally aminated alkynol side chains |
| 04/11/2001 | CN1064360C Fused imidazo [1,2-alpha] pyridines |
| 04/11/2001 | CN1064359C Diindole heterocyclic compounds, preparing method and its use |
| 04/11/2001 | CN1064358C Benyl piperidine derivatives |
| 04/11/2001 | CN1064357C Novel antimicrobial 5-(N-heterosubstiluted amino) quinolones and medicinal composition |
| 04/11/2001 | CN1064356C New piperazine, piperidine and 1,2,5,6-tetrahydropyridine compounds process for preparation thereof, and pharmaceutical composition containing them |
| 04/11/2001 | CN1064354C Trilcyclic benzazepine vasopressin antagnonists |
| 04/11/2001 | CN1064352C Novel cyloakyl derivatives and inhibitors of bone resorption and vitronection receptor antagonists |
| 04/11/2001 | CN1064351C Substituted indanylidineacetylguanidine, process for their paraparation, their use as medicaments ofdiagonstic and medicaments containing them |
| 04/11/2001 | CN1064350C Aryl and heteroaryl alkoxynaphtalene derivatives |
| 04/11/2001 | CN1064349C Novel tricyclic amide, its preparing method and medicinal composition |
| 04/11/2001 | CN1064238C Injection for castracting animals |
| 04/11/2001 | CN1064237C Scar inhibitor and its compounding process |
| 04/11/2001 | CN1064236C Application of pyromeconic acid and heteroside (eigeron glucoside) in pharmacy |
| 04/11/2001 | CN1064235C Pharmaceutical application of glucoside A and B of auricledleaf swallowoft |
| 04/11/2001 | CN1064234C Application of di-caffee acyl-oxy-quininic acid in pharmacy |
| 04/11/2001 | CN1064233C Polynucleotide nutrient product and its preparing process |
| 04/11/2001 | CN1064232C Non freeze-drying powder injection of heart disease curing medicine and preparing method |
| 04/10/2001 | US6215004 Cyclization of mercaptoacetic acid with acetal in solvent; sulfiding |
| 04/10/2001 | US6215002 Cyclization, deblocking, deprotection, sulfonation, condensation, amidation; antiinflammatory agents; respiratory system disorders |
| 04/10/2001 | US6215001 Imidazole derivatives as therapeutic agents |
| 04/10/2001 | US6215000 Crystalline complexes of baccatin III with imidazole, 2-methylimidazole or isopropanol |
| 04/10/2001 | US6214992 Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation |
| 04/10/2001 | US6214991 3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-n-acetic acid, ethyl ester for example; treating complications of diabetes mellitus, such as cataracts, retinopathy, nephropathy, and neuropathy |
| 04/10/2001 | US6214986 Antisense modulation of bcl-x expression |
| 04/10/2001 | US6214978 Antitumor and anticholesterol preparations containing a lipoteichoic acid from streptococcus |
| 04/10/2001 | US6214889 Liquid or gel composition comprising one or more of potassium formate, sodium formate, calcium formate and cesium formate |
| 04/10/2001 | US6214888 Of monocyclic and bicyclic monoterpene diols that stimulate melanogenesis in mammalian skin, hair, wool or fur dependent on enantiomeric configuration |
| 04/10/2001 | US6214887 For preventing or treating hyperproliferative vascular disease |
| 04/10/2001 | US6214884 Composition comprising ketanserin and L-carnitine or an alkanoyl L-carnitine for the treatment of CRPS |
| 04/10/2001 | US6214883 Benzamidoxime prodrugs as antipneumocystic agents |
| 04/10/2001 | US6214882 Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof |
| 04/10/2001 | US6214881 Chemokine sensitive disease |
| 04/10/2001 | US6214880 Lowering plasma cholesterol levels and inhibiting abnormal cell proliferation with said compound; treatment of cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia |
| 04/10/2001 | US6214879 Allosteric inhibitors of pyruvate kinase |
| 04/10/2001 | US6214878 Stilbene compounds comprising an adamantyl group, compositions and methods thereof |
| 04/10/2001 | US6214877 Antidiabetic agents; modulator of glucose concentration |
| 04/10/2001 | US6214876 Indene-1-acetamide sPLA2 inhibitors |
| 04/10/2001 | US6214874 Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4N |
| 04/10/2001 | US6214873 2-aminopropane-1,3-diol compounds, medicinal use thereof, and intermediates in synthesizing the same |
| 04/10/2001 | US6214872 Antiarthritic and anticarcinogenic agents |
| 04/10/2001 | US6214870 Antiarthritic agents; anticancer agents |
| 04/10/2001 | US6214869 Heterocyclic cis cyclopropane derivatives as melatonergic agents |
| 04/10/2001 | US6214868 Side effect reduction, effectiveness |
| 04/10/2001 | US6214867 Anticonvulsant derivatives useful in treating essential tremor |
| 04/10/2001 | US6214866 Composition comprising mupirocin and chlorhexidine |
| 04/10/2001 | US6214865 Anticancer agent |
| 04/10/2001 | US6214864 Formulation of dihydroartemisinin for the control of wide spectrum of malaria |
| 04/10/2001 | US6214863 Synergistic therapy for breast cancer consisting of taxol or taxotere and derivatives, with alkylating agent such as cyclophosphamide and anthracycline antibiotic (daunorubicin or doxorubicin); avoiding/ delaying multi-drug resistance |
| 04/10/2001 | US6214862 Analyzing proteasome sensitivity proteolysis |
| 04/10/2001 | US6214861 Enzyme inhibitor; viricides |
| 04/10/2001 | US6214860 Anticancer agents |
| 04/10/2001 | US6214859 Psychological disorders; alzheimer's disorders; parkinson'sdisorders |
| 04/10/2001 | US6214858 Caspases and apoptosis |
| 04/10/2001 | US6214857 Substituted alkanohydroxamic acids and method of reducing TNFα levels |
| 04/10/2001 | US6214856 Treating neurodegenerative disorders, e.g., alzheimer's disease, strokes, traumatic brain injury; antiischemic agents; muscular dystrophy; also cataracts; platelet aggregation |
| 04/10/2001 | US6214855 Method for the treatment of stroke using N-heterocyclic glyoxlyamide compounds |
| 04/10/2001 | US6214854 Administering adrenoceptor, or antagonist thereof; cardiovascular disorders |
| 04/10/2001 | US6214852 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 04/10/2001 | US6214850 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 04/10/2001 | US6214849 Use of nicorandil in treatment of sexual dysfunction or for enhancement of sexual function in mammals including humans |
| 04/10/2001 | US6214848 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action for prophylaxis and treatment of diabetes; depressing diabetic hyperglycemia |
| 04/10/2001 | US6214847 Treatment of cognitive or neurological dysfunction |
| 04/10/2001 | US6214846 Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
| 04/10/2001 | US6214844 Substituted imidazole compounds |
| 04/10/2001 | US6214843 Preventives and remedies for ischemic intestinal lesion and ileus |
| 04/10/2001 | US6214841 Anticoagulants |
| 04/10/2001 | US6214839 Substituted 6-alkylphenanthridines |
| 04/10/2001 | US6214837 Treating said condition with combination of antihistamines (loratodine) and quinine hydrochloride |
| 04/10/2001 | US6214836 Water soluble analogues of 20(S)-camptothecin |
| 04/10/2001 | US6214833 Made by acylation |
| 04/10/2001 | US6214831 Pharmaceutical composition containing evodiamine compound and method for improving lipid metabolism or antiobesity |
| 04/10/2001 | US6214830 Substituted imidazoles useful in the treatment of inflammatory diseases |
| 04/10/2001 | US6214829 Piperazine compounds, their preparation, and methods of using them |